Printer Friendly

Browse Biotechnology industries topic

Company sales and earnings subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Trinity Biotech reports Q2 adjusted EPS 20.3c vs. 1c last year. Financial report Sep 9, 2021 260
Entasis Therapeutics reports Q2 EPS (29c), consensus (32c). Financial report Aug 11, 2021 292
Harvard Bioscience reports Q2 adjusted EPS 6c, consensus 6c. Financial report Aug 5, 2021 152
Adverum Biotechnologies reports Q2 EPS (45c), consensus (38c). Financial report Aug 5, 2021 243
Myriad Genetics reports Q2 adjusted EPS 12c, consensus (9c). Financial report Aug 3, 2021 205
PURE Bioscience incurs net loss of USD811,000 for Q3 fiscal 2021. Financial report Jun 16, 2021 168
AbbVie, Roche reports positive Venclyxto/Venclexta analysis results. Financial report Jun 11, 2021 206
Trinity Biotech reports Q1 adjusted EPS 10.1c vs. 5.3c last year. Financial report May 25, 2021 203
Arcadia Biosciences reports triple-digit, year-over-year increase in 1Q revenue of 2021. Financial report May 19, 2021 328
Dare Bioscience reports Q1 EPS (16c), consensus (22c). Financial report May 13, 2021 157
TOP NEWS: Moderna swings sharply to quarterly profit on vaccine sales. Financial report May 6, 2021 347
Rigel Pharmaceuticals reports Q1 2021 financial results. Financial report May 6, 2021 236
Rigel Pharmaceuticals reports Q1 2021 financial results. Financial report May 6, 2021 235
IN BRIEF: MorphoSys revenue slumps; optimistic virus headwinds to fade. May 5, 2021 185
Incyte swings to first quarter profit due to sharp cost reduction. Financial report May 4, 2021 285
TOP NEWS: Roche sales fall in first quarter amid firming Swiss franc. Financial report Apr 21, 2021 316
Arcadia Biosciences sees 4Q revenue of $7.1M driven by Bioceres transactions, new wheat and hemp products. Financial report Apr 1, 2021 615
Liminal BioSciences reports 2020 financial results. Financial report Mar 25, 2021 155
Liminal BioSciences reports 2020 financial results. Financial report Mar 25, 2021 156
Trinity Biotech reports Q4 EPS 41c vs. 6.1c last year. Financial report Mar 25, 2021 172
Entasis Therapeutics reports 2020 EPS ($2.10), consensus ($2.39). Financial report Mar 23, 2021 180
Bionano Genomics reports Q1 revenue $3.9M, consensus $3.5M. Financial report Mar 23, 2021 218
Yield10 Bioscience reports Q4 EPS (79c), consensus (70c). Financial report Mar 16, 2021 208
Bristol-Myers Squibb Quarterly Revenue Up But Swings To Loss On Costs. Financial report Feb 4, 2021 301
Meridian Bioscience sees Q2 revenue $57M, one est. $49.3M. Financial report Apr 2, 2020 209
GenScript Biotech generates 18.4% higher overall revenue in 2019. Apr 1, 2020 216
GenScript Biotech generates 18.4% higher overall revenue in 2019. Apr 1, 2020 220
Trinity Biotech reports Q4 EPS 9c vs. 7c last year. Financial report Mar 31, 2020 189
Arcadia Biosciences reports growing commercial revenue in 4Q, sets goal for tenfold increase in 2020. Financial report Mar 26, 2020 742
Precision BioSciences reports FY19 EPS ($2.21), consensus ($2.26). Financial report Mar 10, 2020 152
Nektar Therapeutics reports 2019 financial results. Financial report Feb 28, 2020 157
Nektar Therapeutics reports 2019 financial results. Financial report Feb 28, 2020 161
Proteome Sciences Raise 2019 Earnings Guidance After Boost In Sales. Financial report Feb 11, 2020 185
MaxCyte Shares Rise As It Expects To Report 30% Increase In Revenue. Financial report Jan 20, 2020 278
Pressure BioSciences sees soaring consumables sales in third quarter, projects revenue growth in 2020. Financial report Dec 20, 2019 541
PURE Bioscience Inc incurs lower net loss of USD1.1m for the fiscal first quarter ended 31 October 2019. Financial report Dec 16, 2019 195
PURE Bioscience Inc incurs lower net loss of USD1.1m for the fiscal first quarter ended 31 October 2019. Financial report Dec 16, 2019 191
Twist Bioscience Corporation incurs higher net loss of USD107.7m for fiscal 2019. Financial report Dec 12, 2019 115
Sinovac Biotech Ltd posts net income of USD6.3m for Q3 2019. Financial report Nov 18, 2019 186
Caladrius Biosciences Reports Positive Results for CLBS16 from the ESCaPE-CMD Trial at American Heart Association Scientific Sessions 2019 - Caladrius Biosciences. Financial report Nov 18, 2019 1411
Sinovac Biotech Ltd posts net income of USD6.3m for Q3 2019. Financial report Nov 18, 2019 182
Amgen Reports Positive Analysis Results From Repatha. Financial report Nov 18, 2019 200
The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down. Shanthi Rexaline Calendar Nov 17, 2019 531
Active Biotech widens loss in Q3 2019. Financial report Nov 15, 2019 135
Active Biotech widens loss in Q3 2019. Financial report Nov 15, 2019 136
Caladrius Biosciences Reports 2019 Third Quarter and Nine Month Financial Results and Provides Corporate Update - Caladrius Biosciences. Financial report Nov 7, 2019 1409
Fate Therapeutics reports Q3 EPS (40c), consensus (38c). Financial report Nov 5, 2019 171
Myriad Genetics reports Q1 EPS 8c, consensus 32c. Financial report Nov 4, 2019 141
Seattle Genetics Reports Second Quarter 2019 Financial Results. Financial report Oct 24, 2019 1681
The Daily Biotech Pulse: Biogen Alzheimer's Program Back On Track, Novartis Reports Strong Quarter, Takeda In-Licenses Autoimmune Disorder Drug. Shanthi Rexaline Financial report Oct 22, 2019 966
Roche reports very strong sales growth in the first nine months of 2019 - outlook raised. Financial report Oct 18, 2019 2095
Generex Biotechnology Corporation Discusses Upcoming Revenue Increases and Growth with The Stock Day Podcast. Oct 7, 2019 1165
Amgen Revenue Declines As Patent Expirations Lead To Competition. Sep 16, 2019 202
Harvard Bioscience targets 'modest' organic revenue growth for 2H20. Sep 9, 2019 139
Viva Biotech reports 47.4% rise in net profit for first half. Financial report Aug 29, 2019 177
Vibe Bioscience Reports $31.M In Q2 Consolidated Revenue. Financial report Aug 28, 2019 331
Moleculin Biotech reports Q2 2019 financial results. Financial report Aug 19, 2019 204
Moleculin Biotech reports Q2 2019 financial results. Financial report Aug 19, 2019 200
Precision BioSciences reports Q2 EPS (39c), consensus (47c). Financial report Aug 14, 2019 210
The Daily Biotech Pulse: Jazz Goes Shopping, Portola Offering, Novelion Delays Quarterly Results. Financial report Aug 13, 2019 934
Adaptive Biotechnologies reports Q2 EPS ($1.23), may not compare onsensus (14c). Financial report Aug 13, 2019 108
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Regeneron Reports Second Quarter 2019 Financial and Operating Results -- 6/8/2019. Financial report Aug 13, 2019 1711
Active Biotech reduces loss in Q2 2019. Financial report Aug 9, 2019 174
Active Biotech reduces loss in Q2 2019. Financial report Aug 9, 2019 175
Amicus reports Q2 adj. EPS (36c), consensus (33c). Financial report Aug 8, 2019 116
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) - Regeneron Reports Second Quarter 2019 Financial and Operating Results -- 6/8/2019. Financial report Aug 8, 2019 1712
The Daily Biotech Pulse: Novartis Stands By Zolgensma, GW Pharma Q2 Propelled By Epidiolex Sales, Ionis-Akcea Clinical Readout. Financial report Aug 7, 2019 1738
Compugen reports Q2 2019 financial results. Financial report Aug 6, 2019 259
Compugen reports Q2 2019 financial results. Financial report Aug 6, 2019 255
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion Reports Second Quarter 2019 Results - 24/7/2019. Financial report Jul 31, 2019 1955
Meridian Bioscience reports Q3 adj. EPS 16c, consensus 9c. Financial report Jul 30, 2019 289
The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint. Jul 26, 2019 1202
Harvard Bioscience sees second-quarter revenue beat expectations, reiterates strong guidance. Financial report Jul 26, 2019 391
Harvard Bioscience reports Q2 EPS 4c, consensus 4c. Financial report Jul 25, 2019 109
Seattle Genetics incurs net loss of USD79.2m in Q2 2019. Financial report Jul 17, 2019 187
Seattle Genetics incurs net loss of USD79.2m in Q2 2019. Financial report Jul 17, 2019 183
Alligator Bioscience widens loss in Q2 2019. Financial report Jul 12, 2019 146
Alligator Bioscience widens loss in Q2 2019. Financial report Jul 12, 2019 147
Morphosys--MorphoSys AG Reports First Quarter 2019 Results--7/5/2019. Financial report May 29, 2019 1953
Morphosys--MorphoSys AG Reports First Quarter 2019 Results--7/5/2019. Financial report May 22, 2019 1955
Compugen incurs net loss of USD8.4m for Q1 2019. Financial report May 21, 2019 191
Compugen incurs net loss of USD8.4m for Q1 2019. Financial report May 21, 2019 195
Morphosys--MorphoSys AG Reports First Quarter 2019 Results--7/5/2019. Financial report May 15, 2019 1956
Dare Bioscience reports Q1 EPS (27c), consensus (30c). Financial report May 14, 2019 196
BioGaia profit down by 18% in Q1 2019. Financial report May 9, 2019 190
BioGaia profit down by 18% in Q1 2019. Financial report May 9, 2019 191
Amicus reports Q1 EPS (56c), consensus (31c). Financial report May 8, 2019 184
Morphosys--MorphoSys AG Reports First Quarter 2019 Results--7/5/2019. Financial report May 8, 2019 1956
Active Biotech reduces loss in Q1 2019. Financial report Apr 26, 2019 134
Active Biotech reduces loss in Q1 2019. Financial report Apr 26, 2019 135
Immunovia widens loss in Q1 2019. Financial report Apr 25, 2019 172
XVIVO Perfusion swings to loss in Q1 2019. Financial report Apr 25, 2019 194
Biotage's result up by 5.9% in Q1 2019. Brief article Apr 25, 2019 174
INVO Bioscience incurs higher net loss of USD3.06m in 2018. Financial report Apr 17, 2019 142
Meridian Bioscience sees Q2 revenue $50.0M, consensus $56.37M. Financial report Apr 2, 2019 222
MorphoSys--MorphoSys Presents Results for Fiscal Year 2018--13/3/2019. Financial report Mar 20, 2019 1275
Company Reports Successful Results In Traumatic Brain Injury. Financial report Feb 25, 2019 266
ISCO Reports Successful Results In Traumatic Brain Injury. Financial report Feb 18, 2019 266
ISCO Reports Successful Results In Traumatic Brain Injury. Financial report Feb 18, 2019 267
Neurocrine Biosciences achieves higher net income of USD21.1m for 2018. Feb 6, 2019 239
Neurocrine Biosciences achieves higher net income of USD21.1m for 2018. Feb 6, 2019 235
Neurocrine Biosciences expects net product sales of USD130m for Q4 2018; Provides expected milestones for 2019. Financial report Jan 7, 2019 288
Neurocrine Biosciences expects net product sales of USD130m for Q4 2018; Provides expected milestones for 2019. Financial report Jan 7, 2019 284
Stellar Biotechnologies reports financial results for fiscal year ended September 2018. Financial report Dec 3, 2018 161
Stellar Biotechnologies reports financial results for fiscal year ended September 2018. Financial report Dec 3, 2018 157
Stellar Biotechnologies incurs lower net loss of USD1.76 per basic share for fiscal 2018. Financial report Dec 3, 2018 258
Cantargia widens loss in Q3 2018. Brief article Nov 16, 2018 140
Saniona swings to profit in Q3 2018. Brief article Nov 15, 2018 199
Biotage's result up by 41% in Q3 2018. Brief article Nov 7, 2018 157
Hansa Medical widens loss in Q3 2018. Brief article Nov 2, 2018 196
Onxeo reports Q3 2018 consolidated revenues and provides business update. Financial report Oct 26, 2018 429
Illumina posts higher GAAP net income of USD199m for Q3 fiscal 2018. Financial report Oct 24, 2018 141
Illumina posts higher GAAP net income of USD199m for Q3 fiscal 2018. Financial report Oct 24, 2018 137
Saniona widens loss in Q2 2018. Brief article Aug 23, 2018 118
Biohit swings to loss in H1 2018. Brief article Aug 23, 2018 208
Biotage's net result up by 36% in Q2 2018. Brief article Jul 17, 2018 141
Alligator Bioscience widens loss in Q2 2018. Financial report Jul 13, 2018 131
Alligator Bioscience widens loss in Q2 2018. Financial report Jul 13, 2018 132
Nordic incurs higher comprehensive loss of NOK90.7m for Q1 2018. Brief article May 30, 2018 147
NeuroVive Pharmaceutical reduces loss in Q1 2018. Brief article May 23, 2018 154
Stellar Biotechnologies incurs higher Q2 net loss of USD1.35m. Financial report May 8, 2018 169
Stellar Biotechnologies incurs higher Q2 net loss of USD1.35m. Financial report May 8, 2018 165
Neurocrine Biosciences incurs lower net loss of USD41.8m for Q1 2018. Financial report May 1, 2018 225
Neurocrine Biosciences incurs lower net loss of USD41.8m for Q1 2018. Financial report May 1, 2018 229
AddLife posts profit of SEK26m in Q1 2018. Brief article Apr 30, 2018 124
On The Fly: What to watch in biotech earnings reports. Financial report Apr 30, 2018 388
Nektar incurs lower net loss of USD96.7m for 2017. Financial report Mar 2, 2018 163
AddLife's profit up by 8% in 2017. Brief article Feb 14, 2018 161
Biotage posts increased profit in 2017. Brief article Feb 9, 2018 228
Stellar Biotechnologies incurs lower net loss of USD1.40m for Q1 fiscal 2018. Financial report Feb 8, 2018 199
Wilson Therapeutics reduces loss in Q3 2017. Financial report Nov 24, 2017 172
Active Biotech reduces loss in third quarter 2017. Financial report Nov 10, 2017 136
Active Biotech reduces loss in third quarter 2017. Financial report Nov 10, 2017 137
Active Biotech reduces loss in third quarter 2017. Financial report Nov 10, 2017 132
Probi posts net profit of SEK68.1m in Q3 2017. Financial report Oct 26, 2017 151
BioGaia's profit up by 20% in Q3 2017. Financial report Oct 26, 2017 181
Probi posts net profit of SEK68.1m in Q3 2017. Financial report Oct 26, 2017 152
BioGaia's profit up by 20% in Q3 2017. Financial report Oct 26, 2017 182
Probi posts net profit of SEK68.1m in Q3 2017. Financial report Oct 26, 2017 147
BioGaia's profit up by 20% in Q3 2017. Financial report Oct 26, 2017 177
Saniona widens loss in Q2 2017. Brief article Aug 24, 2017 134
Alligator Bioscience reduces loss in Q2 2017. Financial report Aug 24, 2017 109
Alligator Bioscience reduces loss in Q2 2017. Financial report Aug 24, 2017 110
BioGaia's profit up by 22% in Q2 2017. Financial report Aug 21, 2017 168
BioGaia's profit up by 22% in Q2 2017. Financial report Aug 21, 2017 164
Connection's 2Q earnings smash previous records. Brief article Aug 18, 2017 146
Probi's profit up to SEK59.3m in H1 2017. Financial report Jul 20, 2017 142
Cellect Biotechnology Ltd incurs higher net loss of USD3.4m for Q1 2017. Financial report May 30, 2017 255
Cellect Biotechnology Ltd incurs higher net loss of USD3.4m for Q1 2017. Financial report May 30, 2017 251
Oncopeptides widens loss in Q1 2017. Financial report May 19, 2017 202
Stellar Biotechnologies incurs higher net loss of USD1.10m for Q2 2017. Financial report May 10, 2017 198
Stellar Biotechnologies incurs higher net loss of USD1.10m for Q2 2017. Financial report May 10, 2017 194
Caladrius Biosciences incurs lower net loss of USD6.0m for Q4 2016. Financial report Mar 20, 2017 256
Momenta incurs lower net loss of USD21.0m for 2016. Financial report Feb 22, 2017 141
Shire announces 2016 cumulative results. Financial report Feb 17, 2017 135
Shire announces 2016 cumulative results. Financial report Feb 17, 2017 131
PURE Bioscience posts lower net loss of USD1.6m for Q1 2017. Financial report Dec 15, 2016 168
ISCO reports positive efficacy results in traumatic brain injury. Financial report Oct 31, 2016 376
ISCO reports positive efficacy results in traumatic brain injury. Financial report Oct 31, 2016 377
JSCO reports positive efficacy results in traumatic brain injury. Financial report Oct 24, 2016 375
Probi posts profit of SEK30.3m in Q3 2016; Acquisition of Nutraceutix completed. Brief article Oct 19, 2016 265
BioGaia's profit down by 11% in H1 2016. Brief article Aug 18, 2016 201
Roka Bioscience's net loss narrows to USD7.6m in Q2 2016. Financial report Aug 8, 2016 200
Roka Bioscience's net loss narrows to USD7.6m in Q2 2016. Financial report Aug 8, 2016 196
Merrimack Pharmaceuticals reports Q2 2016 financial results. Financial report Aug 5, 2016 123
Merrimack Pharmaceuticals reports Q2 2016 financial results. Financial report Aug 5, 2016 119
BioGaia posts 22% decline in profit in January to March 2016 quarter. Financial report May 11, 2016 201
Roka Bioscience incurs higher net loss of USD36.6m in 2015. Financial report Mar 7, 2016 130
Allenex posts earnings of SEK15.1m in 2015. Brief article Feb 26, 2016 140
Axactor widens loss in Q4 2015. Brief article Feb 18, 2016 228
Cellectar Biosciences posts Q3 net loss of USD1.9m. Financial report Nov 13, 2015 176
DARA BioSciences posts higher loss of USD2.7m for Q3 2015. Financial report Nov 3, 2015 190
DARA BioSciences posts higher loss of USD2.7m for Q3 2015. Financial report Nov 3, 2015 194
BioGaia's profit after tax up by 44% in Q3 2015. Brief article Oct 26, 2015 201
Trinity Biotech posts higher financial income of USD0.2m for Q3. Financial report Oct 23, 2015 241
Probi posts profit after SEK13.1m in Q3 2015. Brief article Oct 23, 2015 144
Trinity Biotech posts higher financial income of USD0.2m for Q3. Financial report Oct 23, 2015 237
Meridian Bioscience updates net revenues and fiscal 2016 earnings guidance. Financial report Sep 10, 2015 240
Probi posts SEK10.6m profit in Q2. Financial report Jul 16, 2015 109
Aduro Biotech incurs higher net loss of USD16.6m in Q1 2015. Financial report May 29, 2015 186
Aduro Biotech incurs higher net loss of USD16.6m in Q1 2015. Financial report May 29, 2015 182
Rosetta Genomics announces 228% rise in 2014 revenues and double gross billings. Financial report Mar 17, 2015 172
Allenex swings to profit in July to September 2014 quarter. Financial report Nov 28, 2014 116
Cancer Genetics deepens net loss in Q3 2014. Financial report Nov 10, 2014 312
PURE Bioscience incurs higher fiscal 2014 net loss of USD11.1m. Financial report Oct 29, 2014 122
Neurocrine Biosciences posts higher net loss of USD13.4m for Q2 2014. Financial report Aug 7, 2014 142
PURE Bioscience posts higher net loss of USD2.1m for Q3 fiscal 2014. Financial report Jun 11, 2014 133
Enzo Biochem net loss narrows to USD 455,000 in Q3 FY 2013/14. Financial report Jun 10, 2014 268
Amarantus Bioscience Holdings incurs higher net loss of USD5.5m for Q1 2014. Financial report May 22, 2014 142
Atossa Genetics net loss widens to USD 2.4m in Q1 2014. Financial report May 15, 2014 165
Neurocrine Biosciences announces reduced net loss of USD11.8m in Q1 2014. Financial report May 1, 2014 167
Neurocrine Biosciences announces reduced net loss of USD11.8m in Q1 2014. Financial report May 1, 2014 163
Allenex swings to profit in January to March 2014 quarter. Brief article Apr 30, 2014 135
Biotage posts profit of SEK8.1m in Q1 2014. Brief article Apr 29, 2014 186
Interleukin Genetics net loss deepens to USD 1.9m in Q4 2013. Financial report Mar 21, 2014 201
Trinity Biotech net profit inches up to USD 4.6m in Q4 2013. Mar 5, 2014 252
Sequenom's net loss narrows to USD 19m in Q4 2013. Financial report Mar 3, 2014 228
ALNYLAM REPORTS 4TH QTR AND 2013 FINANCIAL RESULTS. Financial report Mar 1, 2014 1301
Seattle Genetics posts higher net loss of USD62.5m in 2013. Financial report Feb 12, 2014 131
Illumina's net profit grows to USD 80.7m in Q4 2013. Jan 30, 2014 237
Biohit: a global, family-owned company embarking on a new phase. Kontinen, Tanja Company overview Jan 1, 2014 8760
Proteome Sciences expects higher revenue in 2013. Dec 4, 2013 138
Allenex reduces loss in third quarter 2013. Brief article Nov 22, 2013 125
Interleukin Genetics' net loss swells to USD 2.2m in Q3 2013. Financial report Nov 18, 2013 198
Puma Biotechnology Inc posts lower net loss of USD14.3m in Q3 2013. Financial report Nov 13, 2013 167
Sinovac Biotech reports unaudited financial results for January to September 2013. Financial report Nov 13, 2013 158
Sinovac Biotech reports unaudited financial results for January to September 2013. Financial report Nov 13, 2013 154
Transgenomic's Q3 2013 net loss expands to USD 5.6m. Financial report Nov 7, 2013 174
Myriad Genetics net profit grows to USD 55.5m in Q1 FY 2013/14. Nov 6, 2013 257
llumina's net profit grows to USD 31.4m in Q3 2013. Oct 22, 2013 242
Illumina inc posts higher GAAP net income of USD31m for Q3 fiscal 2013. Financial report Oct 22, 2013 141
Proteome Sciences net loss widens to GBP 1.7m in H1 2013. Financial report Sep 30, 2013 241
Interleukin Genetics' Q2 2013 net loss deepens to USD 1.8m. Financial report Aug 15, 2013 182
Aeolus Pharmaceuticals Inc falls to net loss of USD786,000 in Q3 fiscal 2013. Financial report Aug 15, 2013 187
Atossa Genetics' net loss widens to USD 2.6m in Q2 2013. Financial report Aug 15, 2013 249
Response Genetics cuts Q2 2013 net loss to USD 1.3m. Financial report Aug 9, 2013 215
Solazyme reports higher net loss for Q2 2013 year over year. Financial report Aug 8, 2013 186
Rigel reduces loss in second quarter of 2013. Financial report Aug 7, 2013 119
Transgenomic's Q2 2013 net loss deepens to USD 2.9m. Financial report Aug 7, 2013 241
i"?Sangamo BioSciences reports H1 financial results. Financial report Jul 25, 2013 116
i"?Sangamo BioSciences reports H1 financial results. Financial report Jul 25, 2013 112
Sequenom's net loss widens to USD 31m in Q2 2013. Financial report Jul 25, 2013 200
Illumina's Q2 2013 net profit rises to USD 35.9m. Financial report Jul 24, 2013 227
PURE Bioscience Inc's net loss narrows to USD1.5m in Q3 fiscal 2013. Financial report Jun 17, 2013 142
Cancer Genetics turns to USD 2.4m net profit in Q1 2013. Financial report May 17, 2013 178
Belgian Ablynx widens Q1 net loss on lower revenues. Financial report May 15, 2013 187
Response Genetics cuts Q1 2013 net loss, improves revenue. Financial report May 14, 2013 148
Transgenomic net loss widens to USD 3.6m in Q1 2013. Financial report May 9, 2013 216
Myriad Genetics net profit rises to USD 38m in Q3 FY 2012/13. Financial report May 8, 2013 252
Neurocrine Biosciences Inc's net loss widens to USD12.1m in Q1 2013. Financial report May 3, 2013 233
BIO-PATH REPORTS FISCAL YEAR 2012 RESULTS. Financial report May 1, 2013 1578
United Therapeutics Corporation posts lower net income of USD62.3m for Q1 2013. Financial report Apr 26, 2013 152
ArQule Inc posts higher net loss of USD10.872m in fiscal 2012. Financial report Mar 15, 2013 153
Belgian Galapagos narrows 2012 net loss to EUR 5.7m. Financial report Mar 8, 2013 173
Momenta Pharmaceuticals Inc falls to net loss of USD58.6m in 2012. Financial report Feb 18, 2013 225
ThermoGenesis Corp's net loss narrows to USD563,000 in Q2 fiscal 2013. Financial report Feb 13, 2013 171
Neurocrine Biosciences Inc posts lower net income of USD5.0m for 2012. Financial report Feb 11, 2013 198
Neurocrine Biosciences Inc posts lower net income of USD5.0m for 2012. Financial report Feb 11, 2013 184
Illumina Inc posts higher GAAP net income of USD151m for fiscal 2012. Financial report Jan 29, 2013 139
Daiichi Sankyo and ArQule report top-line results of Phase 2 signal generation trial of tivantinib. Jan 15, 2013 156
Daiichi Sankyo and ArQule report top-line results of Phase 2 signal generation trial of tivantinib. Jan 15, 2013 152
Aeolus Pharmaceuticals Inc posts higher net income of USD1.7m for fiscal 2012. Financial report Jan 3, 2013 109
Aeolus Pharmaceuticals Inc posts higher net income of USD1.7m for fiscal 2012. Financial report Jan 3, 2013 105
Atossa Genetics Inc posts lower net loss of USD1.14m for Q3 2012. Financial report Dec 21, 2012 182
Atossa Genetics Inc posts lower net loss of USD1.14m for Q3 2012. Financial report Dec 21, 2012 178
PURE Bioscience's net loss narrows to USD2.2m in fiscal Q1 2013. Financial report Dec 13, 2012 113
PURE Bioscience's net loss narrows to USD2.2m in fiscal Q1 2013. Financial report Dec 13, 2012 109
Lifeline Skin Care Corporation reports launch of new sales programmes & multi-media marketing campaigns. Financial report Dec 12, 2012 201
Lifeline Skin Care Corporation reports launch of new sales programmes & multi-media marketing campaigns. Financial report Dec 12, 2012 197
German Biotest's net profit rises by 6.8% Y/Y in 9-mo 2012. Financial report Nov 13, 2012 181
Bavarian Nordic turns to profit in 9-mo, lifts 2012 outlook. Financial report Nov 13, 2012 274
Zealand Pharma cuts 2012 profit outlook despite strong 9-mo. Financial report Nov 13, 2012 214
Danish Topotarget posts deeper loss for 9-mo 2012. Financial report Nov 12, 2012 161
3SBio Inc. reports January to September 2012 financial results. Financial report Nov 12, 2012 151
3SBio Inc. reports January to September 2012 financial results. Financial report Nov 12, 2012 147
3SBio Inc reports growth in revenues but drop in profit for third quarter. Financial report Nov 12, 2012 196
Athersys Inc's net loss widens to USD3.4m in Q3 2012. Financial report Nov 9, 2012 192
PolyMedix Inc posts higher net loss of USD4.38m for Q3 2012. Financial report Nov 9, 2012 173
Evotec records 30.1% Y/Y net profit drop in Q3 2012. Financial report Nov 8, 2012 273
Danish Genmab lifts 2012 guidance despite wider Q3 loss. Financial report Nov 8, 2012 191
Exelixis Inc posts lower net loss of USD32.8m for Q3 2012. Financial report Nov 8, 2012 200
ArQule Inc's net loss narrows to USD431,000 for Q3 2012. Financial report Nov 2, 2012 232
NewLink Genetics Corporation's net loss widens to USD5.9m in Q3 2012. Financial report Nov 1, 2012 186
Neurocrine Biosciences Inc down to net loss of USD3.1m for Q3 2012. Financial report Nov 1, 2012 181
Vitrolife posts SEK8m net income for three months July to September 2012. Financial report Nov 1, 2012 113
Vitrolife posts SEK8m net income for three months July to September 2012. Financial report Nov 1, 2012 114
Cytokinetics Incorporated posts higher net loss of USD10.0m for Q3 2012. Financial report Oct 31, 2012 159
Sangamo BioSciences reports financial results for January to September 2012. Financial report Oct 25, 2012 132
Sangamo BioSciences reports financial results for January to September 2012. Financial report Oct 25, 2012 128
Illumina Inc announces rise in GAAP net income to USD30m for Q3 fiscal 2012. Financial report Oct 24, 2012 157
BUSINESS BRIEFS. Oct 19, 2012 443
YM BioSciences Inc 's net loss narrows to CAD20.3m in fiscal 2012. Financial report Sep 24, 2012 131
ThermoGenesis Corp posts higher net loss of USD5.0m for fiscal 2012. Financial report Sep 21, 2012 140
Senesco Technologies Inc posts lower loss of USD6.692m for fiscal 2012. Financial report Sep 19, 2012 202
Meridian Bioscience Inc expects diluted earnings between USD0.86 per share and USD0.91 per share for fiscal 2013. Aug 29, 2012 184
ShangPharma announces Q2 figures for 2012. Aug 20, 2012 193
ShangPharma announces Q2 figures for 2012. Aug 20, 2012 189
Bio-Path Holdings Inc's Q2 2012 net loss widens to USD787,838. Financial report Aug 17, 2012 188
Aeolus Pharmaceuticals posts lower net income of USD3.064m for Q3 fiscal 2012. Financial report Aug 15, 2012 146
Ligand Pharmaceuticals Incorporated's Q2 net loss widens to USD2.3m. Financial report Aug 9, 2012 158
BUSINESS BRIEFS. Aug 9, 2012 385
Neurocrine Biosciences Inc. reports H1 results. Financial report Aug 1, 2012 130
Neurocrine Biosciences Inc. reports H1 results. Financial report Aug 1, 2012 126
Neurocrine Biosciences Inc drops to net loss of USD0.5m from net income in the previous year. Financial report Aug 1, 2012 201
Dendreon Corporation's net loss narrows to USD96.1m for Q2 quarter 2012. Financial report Jul 31, 2012 140
Sangamo BioSciences Inc reports Q2 results. Financial report Jul 26, 2012 118
Sangamo BioSciences Inc reports Q2 results. Financial report Jul 26, 2012 114
Ceres Inc's net loss widens to USD8.4m in Q3 fiscal 2012. Financial report Jul 13, 2012 205
PURE Bioscience Inc posts unchanged net loss of USD1.8m for Q3. Financial report Jun 14, 2012 146
Synthetic Biologics Sells Clinical Reference Lab. Financial report Jun 1, 2012 835
Oncothyreon Inc swings to net income of USD9.7m in Q1 2012. May 8, 2012 223
NovaBay Pharmaceuticals Inc's net loss widens to USD2.5m in Q1 2012. Financial report May 4, 2012 223
Human Genome Sciences Inc's net loss narrows to USD93.5m in Q1 2012. Financial report Apr 25, 2012 145
Illumina Inc reports preliminary revenue of USD270m for Q1 2012. Financial report Apr 2, 2012 151
AtheroNova Releases 2011 Financial Results. Mar 31, 2012 486
PURE Bioscience posts lesser net loss of USD2.2m for second quarter. Financial report Mar 19, 2012 114
Complete Genomics Inc's net loss widens to USD72.3m in fiscal year 2011. Financial report Mar 9, 2012 152
Trinity Biotech plc's Q4 EPS rises 11.7%. Financial report Mar 6, 2012 201
MiMedx Group Announces Net Loss of $10.2 Million. Financial report Mar 1, 2012 1044
Dendreon Corporation's net loss narrows to USD337.8m in 2011. Financial report Feb 28, 2012 118

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |